Interval-compressed VDC/IE protocol feasibility and outcomes in 27 Ewing's sarcoma patients at a North African center
Compressed chemotherapy showed mixed results for Ewing's sarcoma patients in a small study.
This retrospective, single-institutional cohort study evaluated an interval-compressed VDC/IE protocol in 27 patients with Ewing's sarcoma t…
A small study found that a compressed chemotherapy regimen for Ewing's sarcoma had high toxicity and low survival rates.
Case report finds West Nile virus encephalitis in immunocompromised child after transfusions
Case report links West Nile virus infection to blood transfusions in Saudi Arabia
A case report with cross-sectional donor screening describes a 4-year-old Saudi girl with Ewing's sarcoma who developed WNV encephalitis aft…
A 4-year-old Saudi girl with cancer developed a serious brain infection after receiving blood transfusions, highlighting risks for vulnerabl…
Research across Epithelioid Sarcoma
Related studies from across the Epithelioid Sarcoma family.
Concurrent epirubicin/ifosfamide and radiotherapy boosts RECIST response to 20.3% in high-risk soft-tissue sarcoma
Concurrent chemotherapy and radiation show promise for soft-tissue sarcoma
In this phase III randomized trial of 287 patients with localized high-risk soft-tissue sarcoma, concurrent preoperative epirubicin/ifosfami…
Combining chemotherapy and radiation before surgery may improve tumor shrinkage for patients with high-risk soft-tissue sarcoma.
Isolated gastric Kaposi sarcoma occurs following allogeneic hematopoietic stem cell transplantation in rare cases
Rare Gastric Kaposi Sarcoma Found After Stem Cell Transplant
This case report and literature review identifies 20 cases of Kaposi sarcoma following allogeneic hematopoietic stem cell transplantation. T…
A rare case of stomach cancer linked to stem cell transplants highlights the need for early testing when patients have new digestive symptom…
RPN1 overexpression promotes immune evasion and treatment resistance in multiple malignancies including hepatocellular carcinoma
RPN1 Protein Linked to Worse Outcomes in Several Cancers
This systematic review examines the role of RPN1 in glioma, hepatocellular carcinoma, sarcoma, and triple-negative breast cancer. The author…
High levels of the RPN1 protein are linked to aggressive cancer features and help tumors hide from the body's immune system.
Hybrid fractionation and Lattice boost provide pain relief and necrosis in inoperable pleomorphic liposarcoma
Hybrid Radiation Approach Shows Promise for Inoperable Soft Tissue Sarcoma
This case report and literature review describes a hybrid fractionation approach for a large, inoperable pleomorphic liposarcoma. The treatm…
A new radiation technique may offer pain relief and reduced tumor consistency for patients with large, inoperable soft tissue sarcomas.
Ultrasound-guided biopsy shows high accuracy for diagnosing suspicious myometrial lesions
Ultrasound-guided biopsy shows high accuracy for suspicious uterine tumors
This meta-analysis of 5 studies found that ultrasound-guided biopsy for suspicious myometrial lesions has high diagnostic accuracy, with poo…
A new review confirms that ultrasound-guided biopsies are a safe, highly accurate way to determine if a uterine growth is cancerous.
Targeted cytokine delivery platforms in canine oncology provide data for human immuno-oncology dose selection
Cytokine Therapies Show Potential for Treating Canine Cancers
This mini review synthesizes evidence on targeted cytokine delivery platforms, such as IL-12 and IFN-beta, in dogs with various spontaneous …
New research explores how targeted cytokine delivery systems can treat various cancers in dogs and provide data for future human cancer trea…
Extended resection and intensity-modulated radiotherapy managed a rare primary orbit epithelioid sarcoma
Treatment approach for a rare orbit tumor in a young man
This case report describes the diagnosis and management of a 25-year-old male with primary epithelioid sarcoma of the left orbit. The patien…
A 25-year-old man with a rare eye tumor showed no signs of cancer spread after surgery and targeted radiation therapy.
Protocol for a systematic review and network meta-analysis of second-line soft tissue sarcoma treatments
Protocol outlines options for second-line soft tissue sarcoma treatments
This is a protocol for a systematic review and network meta-analysis. It will evaluate second-line pharmacological regimens for advanced sof…
A new protocol maps second-line drug choices for advanced soft tissue sarcoma patients previously treated with anthracyclines, noting curren…
FDA Approves Pomalyst (pomalidomide) for Multiple Myeloma and Kaposi Sarcoma
FDA approves new drug Pomalyst for multiple myeloma and Kaposi sarcoma.
The FDA approved Pomalyst (pomalidomide) for multiple myeloma in combination with dexamethasone after at least two prior therapies, and for …
The FDA approved Pomalyst (pomalidomide) for two conditions: multiple myeloma and Kaposi sarcoma. It offers a new option for patients who ha…
Post-hoc analysis suggests regional hyperthermia plus chemotherapy may improve survival in extremity soft tissue sarcoma
Adding heat to chemo may improve survival for soft-tissue sarcoma patients
This post-hoc analysis of a randomized trial examined overall survival in patients with extremity soft tissue sarcoma receiving neoadjuvant …
A post-hoc analysis of a randomized trial suggests adding regional hyperthermia to chemotherapy improved survival for patients with extremit…
mGPS associated with survival in advanced soft tissue sarcoma patients receiving trabectedin treatment in retrospective analysis
Blood Work May Predict Who Benefits From Sarcoma Drug
This retrospective cohort study evaluated 60 patients with advanced soft tissue sarcoma treated with trabectedin across multiple tertiary on…
A simple blood test score could help doctors predict how long patients live after starting a specific sarcoma treatment.
Retrospective cohort study assesses delta-NLR and baseline NLR for prognosis in soft tissue sarcoma
A Simple Blood Test Change Could Predict Survival in Sarcoma
This retrospective cohort study included 231 patients with soft tissue sarcoma.
Watching how a blood marker changes during treatment may give sarcoma patients a clearer picture of their future.